| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4161551
Max Phase: Preclinical
Molecular Formula: C30H25N5O4
Molecular Weight: 519.56
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cccn1)CC2)c1ccccc1
Standard InChI: InChI=1S/C30H25N5O4/c1-39-30(38)21-9-11-23-24(16-21)33-29(37)27(23)28(20-6-3-2-4-7-20)32-22-10-8-19-12-15-35(25(19)17-22)26(36)18-34-14-5-13-31-34/h2-11,13-14,16-17,32H,12,15,18H2,1H3,(H,33,37)/b28-27-
Standard InChI Key: HEKLHRGCBLROOS-DQSJHHFOSA-N
Associated Targets(Human)
Fibroblast growth factor receptor 1 9149 Activities
HERG 29587 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Vascular endothelial growth factor receptor 2 20924 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Platelet-derived growth factor receptor beta 5195 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Platelet-derived growth factor receptor 285 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 519.56 | Molecular Weight (Monoisotopic): 519.1907 | AlogP: 4.19 | #Rotatable Bonds: 6 |
| Polar Surface Area: 105.56 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 10.86 | CX Basic pKa: 2.41 | CX LogP: 3.19 | CX LogD: 3.19 |
| Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.29 | Np Likeness Score: -1.34 |
References
| 1. Huang Z, Li H, Zhang Q, Lu F, Hong M, Zhang Z, Guo X, Zhu Y, Li S, Liu H.. (2017) Discovery of Indolinone-Based Multikinase Inhibitors as Potential Therapeutics for Idiopathic Pulmonary Fibrosis., 8 (11): [PMID:29152045] [10.1021/acsmedchemlett.7b00164] |
Source
Source(1):